CD8+-dependent CNS demyelination following ocular infection of mice with a recombinant HSV-1 expressing murine IL-2

Experimental Neurology

Volumn 193, Issue 1, 2005, Pages 1-18

  Osorio, Yanira ^a   La Point, Scott F ^b   Nusinowitz, Steve ^c   Hofman, Florence M ^d   Ghiasi, Homayon ^a  

^a BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Central memory T cells; Cytokines; EAE; HSV 1; MS

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATION; ELECTRON MICROSCOPY; EYE INFECTION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HERPES SIMPLEX VIRUS 1; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MACROPHAGE; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD; T CELL DEPLETION; T LYMPHOCYTE; VIRUS RECOMBINANT; WHITE MATTER; WILD TYPE;

EID: 16244395764     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.expneurol.2004.12.004     Document Type: Article

References (77)

1. K. Adachi, T. Kumamoto, and S. Araki Interleukin-2 receptor levels indicating relapse in multiple sclerosis Lancet 1 1989 559 560
2. Y. Akwa, D.E. Hassett, M.L. Eloranta, K. Sandberg, E. Masliah, H. Powell, J.L. Whitton, F.E. Bloom, and I.L. Campbell Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration J. Immunol. 161 1998 5016 5026
3. S.J. Allen, D. Baker, J.K. O'Neill, A.N. Davison, and J.L. Turk Isolation and characterization of cells infiltrating the spinal cord during the course of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse Cell. Immunol. 146 1993 335 350
4. M.L. Arbones, D.C. Ord, K. Ley, H. Ratech, C. Maynard-Curry, G. Otten, D.J. Capon, and T.F. Tedder Lymphocyte homing and leukocyte rolling and migration are impaired in l-selectin-deficient mice Immunity 1 1994 247 260
5. J.J. Archelos, S. Jung, W. Rinner, H. Lassmann, M. Miyasaka, and H.P. Hartung Role of the leukocyte-adhesion molecule l-selectin in experimental autoimmune encephalomyelitis J. Neurol. Sci. 159 1998 127 134
6. D. Baker, J.K. O'Neill, and J.L. Turk Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitis Cell. Immunol. 134 1991 505 510
7. D. Baker, D. Butler, B.J. Scallon, J.K. O'Neill, J.L. Turk, and M. Feldmann Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins Eur. J. Immunol. 24 1994 2040 2048
8. S. Bansil, R. Troiano, S.D. Cook, and C. Rohowsky-Kochan Serum soluble interleukin-2 receptor levels in chronic progressive, stable and steroid-treated multiple sclerosis Acta Neurol. Scand. 84 1991 282 285
9. B. Becher, B.G. Durell, and R.J. Noelle Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12 J. Clin. Invest. 110 2002 493 497
10. W.S. Begolka, and S.D. Miller Cytokines as intrinsic and exogenous regulators of pathogenesis in experimental autoimmune encephalomyelitis Res. Immunol. 149 1998 771 781
11. J.N. Blattman, J.M. Grayson, E.J. Wherry, S.M. Kaech, K.A. Smith, and R. Ahmed Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo Nat. Med. 9 2003 540 547
12. J. Boman, P.M. Roblin, P. Sundstrom, M. Sandstrom, and M.R. Hammerschlag Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS Neurology 54 2000 265
13. I.L. Campbell, C.R. Abraham, E. Masliah, P. Kemper, J.D. Inglis, M.B. Oldstone, and L. Mucke Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6 Proc. Natl. Acad. Sci. U. S. A. 90 1993 10061 10065
14. I.L. Campbell, A.K. Stalder, Y. Akwa, A. Pagenstecher, and V.C. Asensio Transgenic models to study the actions of cytokines in the central nervous system Neuroimmunomodulation 5 1998 126 135
15. P.B. Challoner, K.T. Smith, J.D. Parker, D.L. MacLeod, S.N. Coulter, T.M. Rose, E.R. Schultz, J.L. Bennett, R.L. Garber, and M. Chang Plaque-associated expression of human herpesvirus 6 in multiple sclerosis Proc. Natl. Acad. Sci. U. S. A. 92 1995 7440 7444
16. C.S. Chiang, H.C. Powell, L.H. Gold, A. Samimi, and I.L. Campbell Macrophage/microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice J. Clin. Invest. 97 1996 1512 1524
17. R.J. Clatch, H.L. Lipton, and S.D. Miller Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs J. Immunol. 136 1986 920 927
18. D.J. Cua, J. Sherlock, Y. Chen, C.A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, S. Zurawski, M. Wiekowski, S.A. Lira, D. Gorman, R.A. Kastelein, and J.D. Sedgwick Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain Nature 421 2003 744 748
19. A. Diab, J. Zhu, B.G. Xiao, M. Mustafa, and H. Link High IL-6 and low IL-10 in the central nervous system are associated with protracted relapsing EAE in DA rats J. Neuropathol. Exp. Neurol. 56 1997 641 650
20. Z. Ding, T.B. Issekutz, G.P. Downey, and T.K. Waddell l-selectin stimulation enhances functional expression of surface CXCR4 in lymphocytes: implications for cellular activation during adhesion and migration Blood 101 2003 4245 4252
21. J.M. Dopp, S.M. Breneman, and J.A. Olschowka Expression of ICAM-1, VCAM-1, l-selectin, and leukosialin in the mouse central nervous system during the induction and remission stages of experimental allergic encephalomyelitis J. Neuroimmunol. 54 1994 129 144
22. D.N. Ernst, W.O. Weigle, D.J. Noonan, D.N. McQuitty, and M.V. Hobbs The age-associated increase in IFN-gamma synthesis by mouse CD8+ T cells correlates with shifts in the frequencies of cell subsets defined by membrane CD44, CD45RB, 3G11, and MEL-14 expression J. Immunol. 151 1993 575 587
23. I.A. Ferber, S. Brocke, C. Taylor-Edwards, W. Ridgway, C. Dinisco, L. Steinman, D. Dalton, and C.G. Fathman Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE) J. Immunol. 156 1996 5 7
24. K. Frei, H.P. Eugster, M. Bopst, C.S. Constantinescu, E. Lavi, and A. Fontana Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis J. Exp. Med. 185 1997 2177 2182
25. J.E. Friedman, M.J. Lyons, G. Cu, D.V. Ablashl, J.E. Whitman, M. Edgar, M. Koskiniemi, A. Vaheri, and J.B. Zabriskie The association of the human herpesvirus-6 and MS Mult. Scler. 5 1999 355 362
26. R. Furlan, E. Brambilla, F. Ruffini, P.L. Poliani, A. Bergami, P.C. Marconi, D.M. Franciotta, G. Penna, G. Comi, L. Adorini, and G. Martino Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes J. Immunol. 167 2001 1821 1829
27. R. Furlan, P.L. Poliani, P.C. Marconi, A. Bergami, F. Ruffini, L. Adorini, J.C. Glorioso, G. Comi, and G. Martino Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice Gene Ther. 8 2001 13 19
28. P. Gallo, M.G. Piccinno, S. Pagni, V. Argentiero, B. Giometto, F. Bozza, and B. Tavolato Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and gamma-IFN levels in serum and cerebrospinal fluid J. Neurol. Sci. 92 1989 9 15
29. H. Ghiasi, S. Bahri, A.B. Nesburn, and S.L. Wechsler Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins Invest. Ophthalmol. Visual Sci. 36 1995 1352 1360
30. H. Ghiasi, S.L. Wechsler, R. Kaiwar, A.B. Nesburn, and F.M. Hofman Local expression of tumor necrosis factor alpha and interleukin-2 correlates with protection against corneal scarring after ocular challenge of vaccinated mice with herpes simplex virus type 1 J. Virol. 69 1995 334 340
31. H. Ghiasi, Y. Osorio, G.C. Perng, A.B. Nesburn, and S.L. Wechsler Recombinant herpes simplex virus type 1 expressing murine interleukin-4 is less virulent than wild-type virus in mice J. Virol. 75 2001 9029 9036
32. H. Ghiasi, Y. Osorio, Y. Hedvat, G.C. Perng, A.B. Nesburn, and S.L. Wechsler Infection of BALB/c mice with a herpes simplex virus type 1 recombinant virus expressing IFN-g driven by the LAT promoter Virology 302 2002 144 154
33. H. Ghiasi, Y. Osorio, G.C. Perng, A.B. Nesburn, and S.L. Wechsler Overexpression of interleukin-2 by a recombinant herpes simplex virus type 1 attenuates pathogenicity and enhances antiviral immunity J. Virol. 76 2002 9069 9078
34. J.C. Glorioso, M.A. Bender, W.F. Goins, D.J. Fink, and N. DeLuca HSV as a gene transfer vector for the nervous system Mol. Biotechnol. 4 1995 87 99
35. B. Gran, G.X. Zhang, S. Yu, J. Li, X.H. Chen, E.S. Ventura, M. Kamoun, and A. Rostami IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination J. Immunol. 169 2002 7104 7110
36. H.P. Hartung, J.J. Archelos, J. Zielasek, R. Gold, M. Koltzenburg, K.H. Reiners, and K.V. Toyka Circulating adhesion molecules and inflammatory mediators in demyelination: a review Neurology 45 1995 S22 S32
37. F.M. Hofman, D.R. Hinton, K. Johnson, and J.E. Merrill Tumor necrosis factor identified in multiple sclerosis brain J. Exp. Med. 170 1989 607 612
38. C.S. Hsieh, S.E. Macatonia, C.S. Tripp, S.F. Wolf, A. O'Garra, and K.M. Murphy Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages [see comments] Science 260 1993 547 549
39. S.F. Hunter, B.G. Weinshenker, J.L. Carter, and J.H. Noseworthy Rational clinical immunotherapy for multiple sclerosis Mayo Clin. Proc. 72 1997 765 780
40. S. Jacobson, H. Shida, D.E. McFarlin, A.S. Fauci, and S. Koenig Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease Nature 348 1990 245 248
41. B.Y. Kang, Y.S. Lim, S.W. Chung, E.J. Kim, S.H. Kim, S.Y. Hwang, and T.S. Kim Antigen-specific cytotoxicity and cell number of adoptively transferred T cells are efficiently maintained in vivo by re-stimulation with an antigen/interleukin-2 fusion protein Int. J. Cancer 82 1999 569 573
42. S.D. Kittur, D.S. Kittur, T.T. Soncrant, S.I. Rapoport, W.W. Tourtellotte, J.E. Nagel, and W.H. Adler Soluble interleukin-2 receptors in cerebrospinal fluid from individuals with various neurological disorders Ann. Neurol. 28 1990 168 173
43. N.K. Koehler, C.P. Genain, B. Giesser, and S.L. Hauser The human T cell response to myelin oligodendrocyte glycoprotein: a multiple sclerosis family-based study J. Immunol. 168 2002 5920 5927
44. K. Kuroda, J. Yagi, K. Imanishi, X.J. Yan, X.Y. Li, W. Fujimaki, H. Kato, T. Miyoshi-Akiyama, Y. Kumazawa, H. Abe, and T. Uchiyama Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen J. Immunol. 157 1996 1422 1431
45. F.M. LaFerla, M.C. Sugarman, T.E. Lane, and M.A. Leissring Regional hypomyelination and dysplasia in transgenic mice with astrocyte-directed expression of interferon-gamma J. Mol. Neurosci. 15 2000 45 59
46. C.Z. Lu, S. Fredrikson, B.G. Xiao, and H. Link Interleukin-2 secreting cells in multiple sclerosis and controls J. Neurol. Sci. 120 1993 99 106
47. F.D. Lublin, R.L. Knobler, B. Kalman, M. Goldhaber, J. Marini, M. Perrault, C. D'Imperio, J. Joseph, S.S. Alkan, and R. Korngold Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis Autoimmunity 16 1993 267 274
48. M. Marella, and J. Chabry Neurons and astrocytes respond to prion infection by inducing microglia recruitment J. Neurosci. 24 2004 620 627
49. R. Martin, H.F. McFarland, and D.E. McFarlin Immunological aspects of demyelinating diseases Annu. Rev. Immunol. 10 1992 153 187
50. A. Minagar, P. Shapshak, R. Fujimura, R. Ownby, M. Heyes, and C. Eisdorfer The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis J. Neurol. Sci. 202 2002 13 23
51. P. Mirandola, A. Stefan, E. Brambilla, G. Campadelli-Fiume, and L.M. Grimaldi Absence of human herpesvirus 6 and 7 from spinal fluid and serum of multiple sclerosis patients Neurology 53 1999 1367 1368
52. R. Mossner, K. Fassbender, J. Kuhnen, A. Schwartz, and M. Hennerici Circulating l-selectin in multiple sclerosis patients with active, gadolinium-enhancing brain plaques J. Neuroimmunol. 65 1996 61 65
53. H. Neumann Molecular mechanisms of axonal damage in inflammatory central nervous system diseases Curr. Opin. Neurol. 16 2003 267 273
54. C.L. Nguyen, M.L. Salem, M.P. Rubinstein, M. Demcheva, J.N. Vournakis, D.J. Cole, and W.E. Gillanders Mechanisms of enhanced antigen-specific T cell response following vaccination with a novel peptide-based cancer vaccine and systemic interleukin-2 (IL-2) Vaccine 21 2003 2318 2328
55. F. Nicoletti, F. Patti, C. Cocuzza, P. Zaccone, A. Nicoletti, R. Di Marco, and A. Reggio Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis J. Neuroimmunol. 70 1996 87 90
56. J.A. Nicoll, E. Kinrade, and S. Love PCR-mediated search for herpes simplex virus DNA in sections of brain from patients with multiple sclerosis and other neurological disorders J. Neurol. Sci. 113 1992 144 151
57. J.H. Noseworthy, C. Lucchinetti, M. Rodriguez, and B.G. Weinshenker Multiple sclerosis N. Engl. J. Med. 343 2000 938 952
58. T. Olsson Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis Immunol. Rev. 144 1995 245 268
59. T. Olsson Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis Neurology 45 1995 S11 S15
60. A. Pagenstecher, S. Lassmann, M.J. Carson, C.L. Kincaid, A.K. Stalder, and I.L. Campbell Astrocyte-targeted expression of IL-12 induces active cellular immune responses in the central nervous system and modulates experimental allergic encephalomyelitis J. Immunol. 164 2000 4481 4492
61. J.M. Petitto, W.J. Streit, Z. Huang, E. Butfiloski, and J. Schiffenbauer Interleukin-2 gene deletion produces a robust reduction in susceptibility to experimental autoimmune encephalomyelitis in C57BL/6 mice Neurosci. Lett. 285 2000 66 70
62. P.L. Poliani, H. Brok, R. Furlan, F. Ruffini, A. Bergami, G. Desina, P.C. Marconi, M. Rovaris, A. Uccelli, J.C. Glorioso, G. Penna, L. Adorini, G. Comi, B. t Hart, and G. Martino Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis Hum. Gene Ther. 12 2001 905 920
63. J.W. Prineas, and R.G. Wright Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis Lab. Invest. 38 1978 409 421
64. J.W. Prineas, E.E. Kwon, N.H. Sternberger, and V.A. Lennon The distribution of myelin-associated glycoprotein and myelin basic protein in actively demyelinating multiple sclerosis lesions J. Neuroimmunol. 6 1984 251 264
65. M.K. Racke, D. Burnett, S.H. Pak, P.S. Albert, B. Cannella, C.S. Raine, D.E. McFarlin, and D.E. Scott Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course J. Immunol. 154 1995 450 458
66. D.L. Rock, A.B. Nesburn, H. Ghiasi, J. Ong, T.L. Lewis, J.R. Lokensgard, and S.L. Wechsler Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1 J. Virol. 61 1987 3820 3826
67. F. Sallusto, D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia Two subsets of memory T lymphocytes with distinct homing potentials and effector functions Nature 401 1999 708 712
68. T. Schwarz Interleukin-12 and its role in cutaneous sensitization Res. Immunol. 146 1995 494 499
69. I. Stamenkovic The l-selectin adhesion system Curr. Opin. Hematol. 2 1995 68 75
70. L. Steinman Myelin-specific CD8 T cells in the pathogenesis of experimental allergic encephalitis and multiple sclerosis J. Exp. Med. 194 2001 F27 F30
71. C. Taus, E. Pucci, E. Cartechini, A. Fie, G. Giuliani, M. Clementi, and S. Menzo Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis Acta Neurol. Scand. 101 2000 224 228
72. U. Traugott, E.L. Reinherz, and C.S. Raine Multiple sclerosis. Distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages J. Neuroimmunol. 4 1983 201 221
73. R.O. Weller, B. Engelhardt, and M.J. Phillips Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways Brain Pathol. 6 1996 275 288
74. W. Weninger, M.A. Crowley, N. Manjunath, and U.H. von Andrian Migratory properties of naive, effector, and memory CD8(+) T cells J. Exp. Med. 194 2001 953 966
75. G.F. Wu, A.A. Dandekar, L. Pewe, and S. Perlman CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination J. Immunol. 165 2000 2278 2286
76. S. Zamvil, P. Nelson, J. Trotter, D. Mitchell, R. Knobler, R. Fritz, and L. Steinman T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination Nature 317 1985 355 358
77. J.C. Zwaagstra, H. Ghiasi, S.M. Slanina, A.B. Nesburn, S.C. Wheatley, K. Lillycrop, J. Wood, D.S. Latchman, K. Patel, and S.L. Wechsler Activity of herpes simplex virus type 1 latency-associated transcript (LAT) promoter in neuron-derived cells: evidence for neuron specificity and for a large LAT transcript J. Virol. 64 1990 5019 5028